Tekla Capital Management LLC Concert Pharmaceuticals, Inc. Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019
SELL
$5.88 - $12.35 $651,815 - $1.37 Million
-110,853 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$9.44 - $13.12 $618,235 - $859,241
65,491 Added 144.37%
110,853 $1.33 Million
Q4 2018

Feb 13, 2019
SELL
$11.25 - $16.17 $510,322 - $733,503
-45,362 Reduced 50.0%
45,362 $569,000
Q3 2018

Nov 13, 2018
BUY
$12.82 - $17.88 $1.16 Million - $1.62 Million
90,724 New
90,724 $1.35 Million

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email